Cargando…
Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation
BACKGROUND: Gastric cancer (GC) represents a malignancy with a multi-factorial combination of genetic, environmental, and microbial factors. Targeting lysosomes presents significant potential in the treatment of numerous diseases, while lysosome-related genetic markers for early GC detection have no...
Autores principales: | Wang, Qi, Liu, Ying, Li, Zhangzuo, Tang, Yidan, Long, Weiguo, Xin, Huaiyu, Huang, Xufeng, Zhou, Shujing, Wang, Longbin, Liang, Bochuan, Li, Zhengrui, Xu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196375/ https://www.ncbi.nlm.nih.gov/pubmed/37215115 http://dx.doi.org/10.3389/fimmu.2023.1182277 |
Ejemplares similares
-
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023) -
GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
por: Zhang, Danfeng, et al.
Publicado: (2023) -
Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
por: Li, Zhangzuo, et al.
Publicado: (2023) -
Machine learning approach combined with causal relationship inferring unlocks the shared pathomechanism between COVID-19 and acute myocardial infarction
por: Liu, Ying, et al.
Publicado: (2023) -
Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)